|
|||||
|
|
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital |
|
| Authors: | Thomas S Y Chan Stephen W Marcella Harinder Gill Yu-Yan Hwang |
| Institution: | 1. Division of Haematology and Haematological Oncology, Department of Medicine, Queen Mary Hospital, Hong Kong, PR China;2. Outcomes Research CORE, Merck &3. Co., Kenilworth, NJ, USA |
| Abstract: | |
| Keywords: | Posaconazole Fluconazole Itraconazole Antifungal prophylaxis Neutropenia Cost-effective Cost-saving |